1. Home
  2. LTBR vs ABSI Comparison

LTBR vs ABSI Comparison

Compare LTBR & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lightbridge Corporation

LTBR

Lightbridge Corporation

HOLD

Current Price

$13.01

Market Cap

578.2M

ML Signal

HOLD

Logo Absci Corporation

ABSI

Absci Corporation

HOLD

Current Price

$3.45

Market Cap

577.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LTBR
ABSI
Founded
1992
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
578.2M
577.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
LTBR
ABSI
Price
$13.01
$3.45
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$7.98
AVG Volume (30 Days)
1.1M
3.9M
Earning Date
11-05-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,815,000.00
Revenue This Year
N/A
$10.72
Revenue Next Year
N/A
$437.79
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.51
$2.01
52 Week High
$31.34
$6.33

Technical Indicators

Market Signals
Indicator
LTBR
ABSI
Relative Strength Index (RSI) 35.88 49.18
Support Level $12.95 $3.37
Resistance Level $15.19 $3.79
Average True Range (ATR) 1.04 0.23
MACD -0.01 -0.00
Stochastic Oscillator 3.02 13.38

Price Performance

Historical Comparison
LTBR
ABSI

About LTBR Lightbridge Corporation

Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through one business segment, which is the development and commercialization of its nuclear fuel. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.

About ABSI Absci Corporation

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

Share on Social Networks: